Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb

Sergei A. Ezhevsky, Hikaru Nagahara, Adita M. Vocero-Akbani, David R. Gius, Michael C. Wei, Steven F. Dowdy*

*Corresponding author for this work

Research output: Contribution to journalArticle

238 Scopus citations

Abstract

In cycling cells, the retinoblastoma protein (pRb) is un- and/or hypo- phosphorylated in early G1 and becomes hyper-phosphorylated in late G1. The role of hypo-phosphorylation and identity of the relevant kinase(s) remains unknown. We show here that hypo-phosphorylated pRb associates with E2F in vivo and is therefore active. Increasing the intracellular concentration of the Cdk4/6 specific inhibitor p15(INK4b) by transforming growth factor β treatment of keratinocytes results in G1 arrest and loss of hypo- phosphorylated pRb with an increase in unphosphorylated pRb. Conversely, p15(INK4b)-independent transforming growth factor β-mediated G1 arrest of hepatocellular carcinoma cells results in loss of Cdk2 kinase activity with continued Cdk6 kinase activity and pRb remains only hypo-phosphorylated. Introduction of the Cdk4/6 inhibitor p16(INK4a) protein into cells by fusion to a protein transduction domain also prevents pRb hypo-phosphorylation with an increase in unphosphorylated pRb. We conclude that cyclin D:Cdk4/6 complexes hypo-phosphorylate pRb in early G1 allowing continued E2F binding.

Original languageEnglish (US)
Pages (from-to)10699-10704
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume94
Issue number20
DOIs
StatePublished - Sep 30 1997

ASJC Scopus subject areas

  • General

Fingerprint Dive into the research topics of 'Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb'. Together they form a unique fingerprint.

  • Cite this